Form D - Notice of Exempt Offering of Securities

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Form D - Notice of Exempt Offering of Securities

Imunon (NASDAQ:IMNN)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Imunon Charts.

Imunon (NASDAQ:IMNN)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Imunon Charts.

Imunon Inc News

IMUNON Announces Continued Strong Improvement in Overall Survival Data from Randomized Phase 2 OVATION 2 Study of IMNN-001
Tuesday 10 December 2024 (2 days ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 27 November 2024 (2 weeks ago) • Edgar (US Regulatory)

IMUNON Announces Results from its End-of-Phase 2 Meeting with the FDA for its Lead IMNN-001 Clinical Program in Advanced Ovarian Cancer
Monday 25 November 2024 (2 weeks ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Thursday 14 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (4 weeks ago) • Edgar (US Regulatory)

IMUNON Presents Positive Data from Phase 2 OVATION 2 Clinical Trial of IMNN-001 in Advanced Ovarian Cancer at SITC 39th Annual Meeting
Thursday 7 November 2024 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 7 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (1 month ago) • Edgar (US Regulatory)

IMUNON Reports Third Quarter 2024 Financial Results and Provides Business Updates
Thursday 7 November 2024 (1 month ago) • GlobeNewswire Inc.

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Thursday 31 October 2024 (1 month ago) • Edgar (US Regulatory)

IMUNON to Hold Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 7, 2024
Thursday 31 October 2024 (1 month ago) • GlobeNewswire Inc.

IMUNON to Present Phase 2 Data of IMNN-001 in Treatment of Newly Diagnosed Ovarian Cancer at SITC 39th Annual Meeting
Wednesday 30 October 2024 (1 month ago) • GlobeNewswire Inc.

More Imunon Inc News Articles

Lightwave Logic

GBT Technologies (PK)

Valiant Eagle (PK)

FuelCell Energy

Accredited Solutions (PK)

Asia Broadband (PK)

Code Green Apparel (PK)

ERHC Energy (CE)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions